Drug Shortage Report for LANTUS

Last updated on 2021-05-10 History
Report ID 137925
Drug Identification Number 02251930
Brand name LANTUS
Common or Proper name Lantus
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) INSULIN GLARGINE
Strength(s) 100UNIT
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 5
ATC code A10AE
ATC description INSULINS AND ANALOGUES
Reason for shortage Other (Please describe in comments)
Anticipated start date 2021-05-12
Actual start date
Estimated end date 2021-05-13
Actual end date 2021-05-07
Shortage status Avoided shortage
Updated date 2021-05-10
Company comments A transportation delay may create a temporarily short term shortage. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Shortage could be avoided as allocation will be put in place.
Health Canada comments
Tier 3 Status No
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2021-05-10 French Compare
v3 2021-05-10 English Compare
v2 2021-04-22 French Compare
v1 2021-04-22 English Compare

Showing 1 to 4 of 4